2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Robot-Assisted UFE Procedure Performed With Hansen Medical’s Magellan System

October 21, 2014—Hansen Medical, Inc. announced the completion of the first robot-assisted uterine fibroid embolization (UFE) in the United States. Sandeep Rao, MD, an i…

US Appeals Court Upholds Florida’s Record Release Law in Medical Liability Suits

October 15, 2014—The AMA Wire, a news publication from the American Medical Association (AMA), reported that a federal appeals court has upheld Florida&rs…

FDA Approves CustomSeal Technology for TriVascular’s Ovation Prime System

October 15, 2014—TriVascular announced that the US Food and Drug Administration has approved its CustomSeal technology for the Ovation Prime endograft system. The custom…

FDA Issues Guidance on Distinguishing Device Recalls From Enhancements

October 15, 2014—The US Food and Drug Administration (FDA) has issued a guidance document for industry and FDA staff that addresses distinguishing medical device recalls…

FDA Approves Bard’s Lutonix 035 Drug-Coated Balloon Catheter

October 10, 2014—Bard Peripheral Vascular, Inc. announced the US Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) cathe…

Phase-III Trial Begins to Evaluate Angiomax in Patients Undergoing Peripheral Endovascular Procedures

October 9, 2013—The Medicines Company reported enrollment of the first patient in a phase-III clinical trial comparing the anticoagulant Angiomax (bivalirudin) to unfrac…

AnGes Begins Global Phase III Clinical Trial of Collategene for CLI

October 6, 2014—AnGes MG, Inc. announced that it has commenced the global phase III clinical trial of Collategene for the treatment of patients with critical limb ischem…

Click here for more News coverage

Current Supplement

Sponsored by TRIVASCULAR, INC.

Protect the Neck

The Ovation Prime® sealing ring preserves the aortic neck with an innovative, less-invasive, clinically proven solution for the broadest range of AAA anatomies.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center






Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media